← Back to All Filings

Stryker Corp VP & Corporate Controller Emily Kay Baculik Files Initial Form 3

Low SignificanceSeptember 8, 2026 at 8:38:01 PM UTC

STRYKER CORP

$SYK3CIK: 0000310764

Subscribe to track SYK

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Form 3 Initial Filing: Stryker Corp ($SYK) šŸ‘¤ Insider: Baculik Emily Kay (VP, Corporate Controller) šŸ“… Effective Date: 2026-09-01 šŸ“¦ Direct Ownership: 1,534 shares Common Stock šŸ’¼ Indirect Ownership: 20 shares (401(k)) šŸ“ˆ Derivative Holdings: 5,538 stock options across 5 grant tranches (2022–2026) āš–ļø Significance: Low (Initial Beneficial Ownership Disclosure)

Comprehensive Analysis

Overview & Summary

On September 8, 2026, Emily Kay Baculik, Vice President and Corporate Controller of Stryker Corp ($SYK), filed an initial Form 3 reporting beneficial ownership of Stryker securities as of September 1, 2026.

Reported Holdings

1. Non-Derivative Securities (Common Stock)

  • Direct Ownership: 1,534 shares
  • Indirect Ownership (401(k)): 20 shares
  • Total Common Stock: 1,554 shares

2. Derivative Securities (Employee Stock Options)

Ms. Baculik holds a total of 5,538 stock options granted under the Stryker Corporation 2011 Long-Term Incentive Plan, which vest 20% annually over five years:

  • Grant 02/02/2022: 805 options at an exercise price of $248.60 (expires 2032-02-01)
  • Grant 02/09/2023: 1,490 options at an exercise price of $268.22 (expires 2033-02-08)
  • Grant 02/07/2024: 1,265 options at an exercise price of $339.77 (expires 2034-02-06)
  • Grant 02/05/2025: 918 options at an exercise price of $392.39 (expires 2035-02-04)
  • Grant 02/04/2026: 1,060 options at an exercise price of $360.82 (expires 2036-02-03)

Significance & Market Impact

Form 3 filings are standard regulatory disclosures required upon assuming a Section 16 reporting officer role and do not represent open-market buying or selling. Therefore, the trading significance is rated Low.

Topics:#Stryker#SYK#Form3#InsiderOwnership#MedTech#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.